Replies to post #9394 on Momenta Pharmaceuticals, Inc. (MNTA)

[MTB]

Separately, if Momenta wins its appeal on the Enoxaparin case (decision expected mid/late 2013) this could provide upside to the stock.

2013??

When are we expecting the Fed Ct. to give a decision/ some insight about potential damage awards and royalties from Amphastar/WPI for infringing MNTA’s lovenox patents??

Cheers,
MTB

[jmkobers]

Not much = a lot.

Continuation of valuation thread we had going. Can't really argue with this analysis, it's spot on.

Does this stock have potential? Sure. Is it a good investment right now? Nope. Interesting that they value mCopax approval at 5/shr. That doesn't even get most longs back to even. Are we @ 80 yet?

Yet another reality check for longs/buying opportunity. How many more until they get it?